Log in
LON:OXP

Oxford Pharmascience Group Share Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume16,260 shs
Average Volume803,502 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.
Read More
Oxford Pharmascience Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.34 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-20-75545875
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive OXP News and Ratings via Email

Sign-up to receive the latest news and ratings for OXP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Oxford Pharmascience Group (LON:OXP) Frequently Asked Questions

What other stocks do shareholders of Oxford Pharmascience Group own?

Who are Oxford Pharmascience Group's key executives?

Oxford Pharmascience Group's management team includes the following people:
  • Marcelo Leonardo Bravo, Chief Executive Officer, Executive Director
  • Christopher Hill, Chief Financial Officer, Executive Director, Company Secretary
  • David Robert Norwood, Non-Executive Chairman of the Board (Age 48)
  • James Nicholas Gerald White, Non-Executive Deputy Chairman of the Board
  • John Geoffery Goddard, Independent Non-Executive Director
  • Karl Robertson Van Horn, Independent Non-Executive Director (Age 80)

What is Oxford Pharmascience Group's stock symbol?

Oxford Pharmascience Group trades on the London Stock Exchange (LON) under the ticker symbol "OXP."

How do I buy shares of Oxford Pharmascience Group?

Shares of OXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford Pharmascience Group's official website?

The official website for Oxford Pharmascience Group is www.oxfordpharmascience.com.

How can I contact Oxford Pharmascience Group?

Oxford Pharmascience Group's mailing address is 2 Royal College Street, LONDON, NW1 0NH, United Kingdom. The company can be reached via phone at +44-20-75545875.

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.